riluzole has been researched along with Spinal Diseases in 1 studies
Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
Spinal Diseases: Diseases involving the SPINE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stukovnik, V | 1 |
| Zidar, J | 1 |
| Podnar, S | 1 |
| Repovs, G | 1 |
1 other study available for riluzole and Spinal Diseases
| Article | Year |
|---|---|
Amyotrophic lateral sclerosis patients show executive impairments on standard neuropsychological measures and an ecologically valid motor-free test of executive functions.
Topics: Algorithms; Amyotrophic Lateral Sclerosis; Back; Cognition Disorders; Depressive Disorder; Diagnosti | 2010 |